It is so sickening to see a man investing his energy, time, and possibly money on a company which he has NO stake on. It just make no sense.
The question is who's the insider at the FDA? I guess we will find out who is going to commit suicide on the other end.
For heaven sake. I have never seen a human being investing his time and possibly money to prove another company is a flaw and illegit. Hope and pray that you are putting the same type of energy on VRX its shareholders (Do you remember us)? People wanted to invest their hard earn money in Herblife, who cares, is it your money or theirs? I just don't get it. Dude, MOVE ON and let Herblife and its shareholders prosper or bankrupt.
I hit you with a like, because the story is somehow believable. But, with no link is nothing but B.S.
Melvin, you are absolutely right, none of us has business giving advices here. Everyone takes his/her own risks. But the fact is Bausch & Lomb will wipe almost half of the company debt since VRX bought it a little over $8B, but worth more than $12 now. Again, there is 18 NDA on their late stages pending FDA approval, ironing or reworking the Wallgeen deal, not to mention the valued of its real state facilities, so to sell at this level is insane. If this drop below $20 level, I will reach for my retirement and buy more. Motely Fool is just taking a shot just like the clown of the street and many others.
You loss is on paper for now unless you sell. Hang in there, Ackman and company are going to come out of this mess, but it will take time. This due isn't an average investor, and he intends to retain his loss by hook or #$%$. I'm leaning toward the first one of course! Hang in there man.
I disagree with you regard to NO company is going to touch it. Bausch & Lomb is worth 12B alone or more at the current time. VRX has 18 NDA in the pipeline at their late stages, not to mention its facilities. I'm certain it does worth above $45, and my only concern Ackman and board refusal to sell since he himself got in at the $100's level, and wont settle for less than what he paid.
Everyone is thinking of those who bought this stock under $50, and NO regard to those who bought above $100 a share or $200 for that matter. Got myself into a hole here around $60, and I will sell in a heart beat to any $45 bidder.
" Valeant Pharmaceuticals International Inc. VRX, +0.18% said Friday it is investing $27.5 million in its Canadian manufacturing and export capacity with plans to upgrade facilities in Steinbach, Manitoba and Laval, Quebec"
He is trying to average out if or when a hostile takeover comes through. Many scavengers are trying to prey on this company weakness and mismanagement where Takeda was the first to show up last week.
The Connecticut-based asset manager added a 165,000-share position in Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) to its portfolio during the first three months of 2016, which was valued at $4.34 million on March 31.